Molecular Prognosis of Cardiogenic Shock Patients under Extracorporeal Membrane Oxygenation (methylation). Homo sapiens

Prognosis for cardiogenic shock patients under ECMO (extracorporeal membrane oxygenation) was our study goal. Success defined as survived more than 7 days after ECMO installation and failure died or had multiple organ failure in 7 days. Total 34 cases were enrolled, 17 success and 17 failure. Peripheral blood mononuclear cells collected at ECMO installation were used analyzed. Overall design: Analysis of the cardiogenic shock patients at extracorporeal membrane oxygenation treatment by methylation. DNA methylation between successful and failure groups were analyzed.